National Stroke Foundation

UVADEX Sterile Solution

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved February 1999

Specific Treatments:


Therapeutic Areas

General Information

UVADEX (methoxsalen) Sterile Solution with the UVAR® Photopheresis System has been approved for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.